AnnalsATS

HomeJournalsAnnalsATS ▶ NIV in COPD Exacerbations
NIV in COPD Exacerbations

By David Lederer, MD, editor, Annals of the American Thoracic Society
Follow Dr. Lederer on Twitter @AnnalsATSEditor

Successful Use of Noninvasive Ventilation in Chronic Obstructive Pulmonary Disease: How Do High-Performing Hospitals Do It?

Although the benefits of non-invasive ventilation for treating acute exacerbations of COPD are well established, including lower mortality, one study found that only about a third of patients who met the criteria for an NIV trial before intubation were started on NIV. In their November Annals of the American Thoracic Society study, Kimberly A. Fisher MD, MSc, and her coauthors describe the results of their effort to find out why patients at some hospitals are more likely to be treated with NIV. They interviewed respiratory therapists, nurses, and physicians from seven high-performing hospitals and found that early initiation of NIV, frequent re-assessment of patients, proper respiratory therapist staffing levels, and respiratory therapist autonomy were among the key factors for maximizing the number of patients treated with NIV.

November Highlights

Usual Interstitial Pneumonia Can Be Detected in Transbronchial Biopsies Using Machine Learning

An Observational Study of Outcomes and Tolerances in Patients with CysticFibrosis Initiated on Lumacaftor/Ivacaftor

Greater Cognitive Deficits with Sleep-Disordered Breathing among Individuals with Genetic Susceptibility to Alzheimer’s Disease: The Multi-Ethnic Study of Atherosclerosis



November 2017